Irregular
Irregular is a frontier AI security lab that performs red teaming, safety evaluations, and misuse testing on advanced models.
Secondary Market Price
Secondary Market Price
How Irregular Measures Up
To help you manage your Irregular equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are still gathering data to finalize our rating for Irregular. Please check back soon for our projection of the company's worth four years from now.
Exit Risk
TBD
We are still gathering data on Irregular to train our machine learning model. Check back soon for our exit risk rating for Irregular!
Funding Stage
Series C
For a potential employee, a Series C company like Irregular offers more stability than an earlier-stage startup because it has a proven business model. You'd be joining a company that is focused on scaling up, which means there are still plenty of opportunities to make a significant impact.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Irregular's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Irregular Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Irregular's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Irregular is a frontier AI security lab that evaluates and stress-tests advanced artificial intelligence models. The company partners with leading AI labs, including Anthropic, Google DeepMind, and OpenAI, to uncover vulnerabilities and improve model security before public deployment. Its services include red teaming, safety evaluations, and misuse testing, with specific work on models like Claude Sonnet 4.5 and GPT-5. Founded in 2023 as Pattern Labs, the company is the creation of co-founders Dan Lahav and Omer Nevo and is headquartered in Tel Aviv, Israel.
Looking forward, Irregular plans to scale its mission of securing advanced AI systems by continuing to partner with model labs and regulators to help set industry standards. The company recently announced it had raised $80 million in a Series A funding round led by Sequoia Capital and Redpoint to support this goal. Recent activities also include CEO Dan Lahav’s participation as an invited expert at a European Commission AI Office session and the publication of research, such as a whitepaper on confidential inference systems co-authored with Anthropic.
- Sequoia Capital
- Redpoint
- Co-Founder, CEO Dan Lahav
- Co-Founder, Omer Nevo
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Irregular worth joining?
Deciding to join any private company depends on its growth potential, leadership, and how it aligns with your career goals. Platforms like Prospect can help you evaluate a startup's potential by providing data-driven projections and insights similar to those used by venture capitalists.
What should I do with my Irregular stock?
Managing private stock involves understanding its potential value and creating a strategy for taxes and eventual liquidity. You can use a service like Prospect to model different scenarios, optimize your option exercise strategy, and minimize your tax burden.
Can you sell Irregular stock?
Selling stock in a private company is possible but typically restricted to specific events like tender offers, secondary market sales, or an acquisition. These opportunities are less frequent than in public markets and are governed by the company's specific policies and transfer restrictions.
How can I find the value of my Irregular stock?
The value of private stock is not publicly available and is typically determined by the company's latest 409A valuation or recent funding rounds. To get a forward-looking estimate, you can use tools from Prospect, which uses predictive models to project the future value of your equity.
What is Irregular's equity worth?
A private company's equity value is based on its overall valuation, which is set by investors during fundraising rounds. While this information isn't always public, platforms that analyze private companies can provide projections based on market data and growth metrics.
What is Irregular's stock ticker symbol?
As a private company, Irregular does not have a stock ticker symbol because its shares are not traded on a public stock exchange. Ticker symbols are only assigned to companies once they complete an Initial Public Offering (IPO).
Can I buy or sell Irregular stock?
Buying stock in a private company is generally limited to accredited investors during funding rounds, while selling is restricted to company-approved liquidity events. Prospect offers tools to help employees navigate selling opportunities, such as tender offers, but does not facilitate the direct purchase of shares.
What is the criteria to buy or invest in Irregular stock?
Investing in a private startup is typically reserved for venture capital firms and accredited investors who meet specific income or net worth requirements set by regulators. Employees, however, can acquire equity through compensation packages, such as stock options or RSUs, without meeting these investor criteria.
